These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2468007)

  • 41. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
    Fearon DT
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Genetics of complement: recent aspects (author's transl)].
    Hauptmann G
    Ann Immunol (Paris); 1982; 133C(2):211-9. PubMed ID: 7051953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.
    Devine DV; Siegel RS; Rosse WF
    J Clin Invest; 1987 Jan; 79(1):131-7. PubMed ID: 2432087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T; Lavoie S; Nussenzweig V
    J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High resolution isoelectric focusing of immunoprecipitated proteins under denaturing conditions. A simple analytical method applied to the study of complement component polymorphisms.
    Rodriguez de Córdoba S; Rubinstein P; Ferreira A
    J Immunol Methods; 1984 Apr; 69(2):165-72. PubMed ID: 6232323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternative pathway of complement.
    Pangburn MK
    Methods Enzymol; 1988; 162():639-53. PubMed ID: 2976114
    [No Abstract]   [Full Text] [Related]  

  • 47. Complement in host defense.
    Schultz DR
    Scand J Infect Dis Suppl; 1980; Suppl 24():22-9. PubMed ID: 7010559
    [No Abstract]   [Full Text] [Related]  

  • 48. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.
    Kotwal GJ; Moss B
    Nature; 1988 Sep; 335(6186):176-8. PubMed ID: 3412473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME; Kinoshita T; Nussenzweig V
    J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors.
    Seya T; Okada M; Hazeki K; Nagasawa S
    Mol Immunol; 1991; 28(4-5):375-82. PubMed ID: 1829503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inherited disorders of complement.
    Guenther LC
    J Am Acad Dermatol; 1983 Dec; 9(6):815-39. PubMed ID: 6315788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decay-accelerating factor and membrane cofactor protein.
    Lublin DM; Atkinson JP
    Curr Top Microbiol Immunol; 1990; 153():123-45. PubMed ID: 1688754
    [No Abstract]   [Full Text] [Related]  

  • 53. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M; Okada H
    J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.
    Singhrao SK; Neal JW; Rushmere NK; Morgan BP; Gasque P
    Am J Pathol; 2000 Sep; 157(3):905-18. PubMed ID: 10980130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of complement via the alternative pathway.
    Pangburn MK
    Fed Proc; 1983 Jan; 42(1):139-43. PubMed ID: 6217084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A monomeric human C4b-binding protein (C4bp) more efficiently inactivates C3b than natural C4bp: participation of C-terminal domains in factor I-cofactor activity.
    Mikata S; Miyagawa S; Fukui A; Murakami Y; Shirakura R; Matsuda H; Hatanaka M; Matsumoto M; Seya T; Suzuki K; Nagasawa S
    Mol Immunol; 1998 Jun; 35(9):537-44. PubMed ID: 9809581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factor H-related proteins determine complement-activating surfaces.
    Józsi M; Tortajada A; Uzonyi B; Goicoechea de Jorge E; Rodríguez de Córdoba S
    Trends Immunol; 2015 Jun; 36(6):374-84. PubMed ID: 25979655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetics and biosynthesis of complement proteins.
    Colten HR; Alper CA; Rosen FS
    N Engl J Med; 1981 Mar; 304(11):653-6. PubMed ID: 6450325
    [No Abstract]   [Full Text] [Related]  

  • 60. Animal models of inherited complement deficiency.
    Linton S
    Mol Biotechnol; 2001 Jun; 18(2):135-48. PubMed ID: 11471455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.